Lv32
364 积分 2023-07-07 加入
Site-Specific Antibody–Drug Conjugation Using Microbial Transglutaminase
22天前
已完结
A Dual-Target and Dual-Mechanism Design Strategy by Combining Inhibition and Degradation Together
28天前
已完结
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
28天前
已完结
Synergistic Combination Activity of the Novel GSPT1 Degrader CC-90009 in Acute Myeloid Leukemia Models
28天前
已关闭
Synergistic Combination Activity of the Novel GSPT1 Degrader CC-90009 in Acute Myeloid Leukemia Models
28天前
已关闭
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers
2个月前
已完结
Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
2个月前
已完结
Exploiting Synthetic Lethality in PDAC with Antibody Drug Conjugates and ATR inhibition
2个月前
已完结
Discovery of a Potent and Selective GSPT1 Molecular Glue Degrader for the Treatment of Castration-Resistant Prostate Cancer
2个月前
已完结
Discovery of new Lenalidomide derivatives as potent and selective GSPT1 degraders
2个月前
已完结
Abstract 2895: Characterization of payload release from a novel camptothecin drug-linker
皖公网安备34019202002308
